Cryolife, Inc. operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cryolife with three other
companies in this sector in UNITED STATES :
sales of $230.81 million
of which 35%
was Open Ablation - United states),
of which 44%
was Vascular Interventions & Therapies), and
Cardiovascular Systems, Incorporation
of which 72%
was Peripheral Products).
During the year ended December of 2019, sales at
Cryolife were $276.22 million.
increase of 5.1%
versus 2018, when the company's sales were $262.84 million.
This was the fifth consecutive year of sales increases at Cryolife
(and since 2014, sales have increased a total of 91%).
Sales of Medical Devices saw an increase
5.3% in 2019, from
$187.39 million to $197.25 million.